I keep telling everyone with CFS here they have Lyme and co-infections and its TREATABLE.
Oh well, I try.
I read a study a few years back that said 40% of PWC have Lyme, so it is not everyone with CFS. Also, Lyme is hard to treat if you have bad detox genetics, as most PWC have. Probably we need to get the CFS managed and our immune system working again before we are likely to make much of a dent in Lyme.
I don't think that this is question of validity. My first thought is that it is a question of sensitivity. The original 67% of the WPI CFS patients tested positive via PCR. Of the remaining 33 CFS patients that had negative PCR tests, the WPI was able to culture WXRV virus from the blood samples of 30 out of those 33.
True, that culture of the 30/33 was interesting, but the culture uses antibodies, which has some issues: 1) WPI used MuLV antibodies and according to one review of research, some MuLV antibodies cross-react with some HERV types, and PWC have high rates of activated HERV per the WPI May presentation and also per research at Tufts; 2) WPI did not publish their results of the antibody study for the control group, so we do not know whether that 30/33 is unique for CFS, or whether the MuLV antibody would have also found an antigen at that rate in the controls. They can cite the literature for standard control rates of positive on MuLV antibodies, but that does not validate their antibody test, they have to run controls in their lab using their reagents, the same test must be run on both the CFS samples and controls. Maybe WPI did that but it was not reported in their Science article.
Of course, that's also true. But if they're finding positive results for XMRV, my impression -- which may or may not be correct, to be fair -- is that that means the patient does have XMRV. We don't, of course, know that it means anything else at this point, in terms of causes to symptoms or anything else -- just that XMRV was present in the patient's sample.
Problem is, a negative result at this point can't easily be verified as being correct. It could be correct. It could not be correct. We just don't know, and that's regardless of whether XMRV itself is involved in the symptoms of CFS. That's a separate question, and I think you're absolutely right to remind people that we don't have data on anything but a correlation at this point, and one that still needs published replication studies at that.
I'd just caution people not to assume that current test results are absolutely correct on just the question of XMRV presence or absence, regardless of what we find XMRV to mean in the larger sense over time. Testing will change. Understanding of meaning of the results will change. It's very early to be making a whole lot of assumptions about any of it right now.
Yes, too early to be making assumptions.
Also, a negative result on a standard PCR is pretty strong. False positives are more common than false negatives for the type of PCR test that WPI used. I have heard that VIP is using one of the original prostate cancer tests, which I believe was standard PCR.
I doubt many people are operating under any assumptions at this point. More like trying to keep hope alive. I say, good on 'em.
We do need to keep hope alive. But hope should always be based on what is or can be reality. We do not yet know if XMRV is reality for CFS. So for me anyway my hope is that regardless of the outcome of the XMRV replications, more productive CFS research is in our future.